Rx Import Bill Prohibits Contracts To Prevent Return Shipments To U.S.
Executive Summary
Drug manufacturers would not be able to use contracts with foreign distributors to prohibit reimportation of their products under the version of the prescription drug import amendments approved by the Agriculture Appropriations conference Oct. 5.
You may also be interested in...
Reimportation
Agriculture Appropriations Conference Report passes the House Oct. 11 by a vote of 340 to 75. The report includes language that would allow the reimportation of prescription drugs (1"The Pink Sheet" Oct. 9, p. 7). The Senate began debating the measure Oct. 13 and will vote on the report Oct. 18
Reimportation
Agriculture Appropriations Conference Report passes the House Oct. 11 by a vote of 340 to 75. The report includes language that would allow the reimportation of prescription drugs (1"The Pink Sheet" Oct. 9, p. 7). The Senate began debating the measure Oct. 13 and will vote on the report Oct. 18
Rx Import Bill Undercuts FDA Approach To Quality Control, Lilly Exec Testifies
FDA's process focus in GMP regulation illustrates the importance of manufacturer control over importation into the U.S., Lilly Europe/North America Area Quality Control Leader Nikki Mehringer told the House Commerce/Oversight Subcommittee Oct. 3.